Tag Archives: ISO 14155

CORONAVIRUS AND CLINICAL STUDIES: WHAT TO DO?

By now the Coronvirus outbreak is affecting everyday life worldwide (see latest statistics Johns Hopkins University), and to avoid patient exposure or to reduce the burden on clinical services it also started impacting clinical trials; their execution, monitoring, and publications. … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , | 3 Comments

2020 – THE 11th HOUR FOR THE MDR, ISO 14155, & OTHER EU CLINICAL MATTERS

  Nothing could have been more illustrative for the medical device clinical trial environment in Europe  than the storms Ciara and Dennis in February. With BREXIT as a kick off, the Coronavirus spreading around te globe, the MDR deadline less … Continue reading

Posted in Uncategorized | Tagged , , , , , , | 2 Comments

A NEW VERSION OF ISO 14155: WHAT TO EXPECT?

The MDR as well as the current version of MEDDEV 2.7/1 reference ISO 14155 as GCP standard for medical device clinical investigations. Indeed, the 2011 version, but the third edition is in the making, so it can be good to … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | 7 Comments

THE MEDICAL DEVICE CLINICAL TRIAL ENVIRONMENT IN EUROPE

One of the topics discussed during the Medical Device Clinical Trial Seminar in Taipei, was the current medical device clinical trial environment in Europe and how that is evolving. A short version of my presentation, you can find on SlideShare … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

CLINICAL EVALUATIONS & CLINICAL TRIALS IN THE EU – TAIPEI

I am very much looking forward to the Medical Device Clinical Trial Regulations and Practice Seminar in Taipei September 5th, where I will be speaking on the current EU standards regarding Clinical Evaluations and Clinical Trials as well as the … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

Clinical evidence under the EU Medical Device Regulation: More firework on the way.

The EU Medical Device Regulation (MDR) and the In Vitro Diagnostic device Regulation (IVDR) entered into force, local governments published guidance how to deal with the new medical device regulations, there is debate on the implementation of the MEDDEV 2.7/1 … Continue reading

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

INVESTIGATOR CLINICAL STUDIES: FOUR KEY THINGS TO DO

Last week some-one asked me what it is that industry can and can not do in investigator initiated trials (IITs). The challenge in answering this question goes back to the question who the sponsor – and therefore the one being … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , | 2 Comments

FOUR (NOT) TO DO’S TO PREVENT PAPER WITHDRAWAL

The vote regarding the proposed Medical Device Regulation is once more postponed, so we will need some more patience before knowing where we are heading in Europe with the Medical Device Directive. One thing, however, speaks clearly from the proposal … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment